Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-04-04
2009-08-25
Andres, Janet L (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
07579471
ABSTRACT:
The present invention provides compounds of formula (I)wherein X, Y, R1, R2and R3are as defined hereinabove.The compounds of the present invention are modulators, especially antagonists, of the activity of chemokine CCR5 receptors. Modulators of the CCR5 receptor may be useful in the treatment of various inflammatory diseases and conditions, and in the treatment of infection by HIV and genetically related retroviruses.
REFERENCES:
patent: 6855724 (2005-02-01), Basford et al.
patent: 7217721 (2007-05-01), Basford et al.
patent: 40107 (1986-10-01), None
patent: 39877 (1992-03-01), None
patent: 4399 (1998-01-01), None
patent: 253602 (2001-11-01), None
patent: 1118858 (2001-07-01), None
patent: WO 9111172 (1991-08-01), None
patent: WO 9402518 (1994-02-01), None
patent: WO 9526401 (1995-11-01), None
patent: WO 9708166 (1997-03-01), None
patent: WO 9855148 (1998-12-01), None
patent: WO 9931099 (1999-06-01), None
patent: WO 0038680 (2000-07-01), None
patent: WO 0039125 (2000-07-01), None
patent: WO 0109134 (2001-02-01), None
patent: WO 0190106 (2001-11-01), None
Shah et. al. Bioorganic & Medicinal Chemistry Letters 2005, 15, 977-982.
Terry Kenakin and Ongun Onaran “The ligand paradox between affinity and efficacy: can you be there and not make a difference?” Trends in Pharmacological Sciences 2002, 23, 275-280.
Mueller et. al. British Journal of Pharmacology 2002 135, 1033-1043.
Borisy et. al. “Systematic discovery of multicomponent therapeutics” PNAS 2003, 100, 7977-7982.
Grant R. Zimmermann “Multi-target therapeutics: when the whole is greater than the sum of the parts.” Drug Discovery Today 2007, 12, 34-42.
West, Anthony R., Solid State Chemistry and its Applications, Wiley, New York, 1988, pp. 358 & 365.
Berge, et aI., “Pharmaceutical Salts”, Journal of Pharmaceutical Sciences, 1977, 1-19, vol. 66, No, 1.
Bungaard, H., Design of Prodrugs:, Elsevier Press. 1985, Amsterdam, New York, Oxford.
Cascieri, M., e al., “The Chemokine/Chemokine Receptor Family: Potential and Progress for Therapeutic lntervention”, Current Opinion in Chemical Biology, 2000, 4 : 420-427, vol. 4. No. 4.
Combadiere, et al., “Cloning and Functional Expression of CC CKR5, a Human Monocyte CC Chemokine Receptor Selective for MIP-α, MIP-1α, and RANTES”, Journal of Leukocyte Biology. 1996, 147-152, vol. 60.
Connor, et al., “Vpr is Required for the Efficient Replication of Human Immunodeficiency Virus Type-1 in Monconuclear Phagocytes”, Virology, 1995, 935-944, vol. 206.
Demitrov, et al., “Microculture Assay for Isolation of Human Immunodeficiency Virus Type 1 and for Titration of Infected Peripheral Blood Mononuclear Cells”, Journal of Clinical Microbiology. 1990, 734-737, vol. 28, No. 4.
Greene, T., et al., “Protection for the Amino Group,” Protective Groups in Organic Synthesis, 3thedition, John Wiley and Sons, 1999, 493-653.
Hesseigesser, J., et al., Identification and Characterization of Small Molecule Functional Antagonists of the CCR1 Chemokine Receptor, The Journal of Biological Chemistry, 1998, 273(25), 15687-15692.
March, J., Advanced Organic Chemistry, 4thedition, John Wiley and Sons, 1992, 652.
Basford Patricia Ann
Stephenson Peter Thomas
Taylor Stefan Colin John
Wood Anthony
Andres Janet L
Benson Gregg C.
Creagan B. Timothy
O'Dell David K
Pfizer Inc.
LandOfFree
Tropane derivatives useful in therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tropane derivatives useful in therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tropane derivatives useful in therapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4115412